Quarterly report pursuant to Section 13 or 15(d)

10. Segment and Geographic Information (Tables)

v3.3.1.900
10. Segment and Geographic Information (Tables)
9 Months Ended
Dec. 31, 2015
Segment Reporting [Abstract]  
Segment and Geographic Information
    Three Months     Nine Months  
    Ended     Ended  
    December 31,     December 31,  
Geographic region   2015     2014     2015     2014  
United States   $ 1,010,000     $ 647,000     $ 2,983,000     $ 1,358,000  
Latin America     1,261,000       1,076,000       4,085,000       3,336,000  
Europe and Rest of World     1,202,000       751,000       2,725,000       1,977,000  
      3,473,000       2,474,000       9,793,000       6,671,000  
Product license fees and royalties     120,000       555,000       906,000       2,601,000  
Total product related revenues   $ 3,593,000     $ 3,029,000     $ 10,699,000     $ 9,272,000  
License fees and royalties by partner
    Three Months     Nine Months  
    Ended     Ended  
    December 31,     December 31,  
Partner   2015     2014     2015     2014  
Exeltis (formerly Quinnova)   $ 44,000     $ 54,000     $ 201,000     $ 361,000  
Innovacyn           123,000       29,000       1,110,000  
Laboratorios Sanfer (formerly More Pharma)     76,000       378,000       676,000       1,130,000  
Total product license fees and royalties   $ 120,000     $ 555,000     $ 906,000     $ 2,601,000